This study investigates unresectable locally advanced or metastatic solid tumors. It evaluates the safety and tolerability of different investigational treatments for various tumor types, including clear cell renal cell cancer, pancreatic ductal adenocarcinoma, colorectal cancer, and urothelial carcinoma.
The study focuses on assessing the safety, tolerability, and imaging characteristics of investigational medications. It also evaluates the effectiveness of these treatments in managing the condition.
- Who can participate: Participants must have unresectable locally advanced or metastatic solid tumors such as clear cell renal cell cancer, pancreatic ductal adenocarcinoma, or colorectal cancer. They should have received prior treatments and have measurable disease.
- Study details: Participants will receive investigational medications to evaluate their safety, tolerability, and effectiveness. Some participants may receive a placebo.
How understandable was the trial content above?
Hard to understand
Easy to understand